The rapid increase in demand for mRNA therapeutics has revealed the inherent challenge of the platform—that the production of mRNA is facing a series of bottlenecks. In this sponsored GEN webinar, we will hear how scientists at Sartorius have been working on streamlining these challenges long before the pandemic even started.
In this GEN webinar, sponsored by the CustomBiotech division of Roche, we will hear about some of the latest benefits when automating next-generation sequencing sample preparation.
In this GEN webinar, sponsored by WuXi, our panel of experts will discuss a range of biophysical technologies, as MST/TRIC (temperature-related intensity change), SPR, and nano-differential scanning fluorimetry to support drug discovery programs.
This GEN webinar, sponsored by Unchained Labs, will show that whether a nanoparticle’s payload is RNA, DNA, protein, or another API, Big Tuna handles buffer exchange and concentration while Stunner delivers dye-free, label-free, standard-free, hassle-free quant.
In some of the newest cell and gene therapies, the drug itself is subvisible in nature. So, how do you tell a good particle (like a cell) that should go into a patient from a harmful particle that should not? In this GEN webinar, sponsored Halo Labs, we are going to hear about a new way to determine the good and the bad from our distinguished presenter Dr. Bernardo Cordovez. We will learn about case studies measuring stability and purity of CAR-T cell therapies and AAV gene therapy products using the Aura CL™—an instrument designed specifically to detect, count, size, and identify subvisible biological aggregates and extrinsic materials for product quality measurements in cell and gene therapy applications.